We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Ciclopirox 8% nail lacquer (topical antifungal)
A topical antifungal nail lacquer for fungal nail infection. It clears the fungus in roughly a third of people and leaves a normal-looking nail in far fewer.
Prescription medication — not a dietary supplement
Ciclopirox is a prescription (or investigational) drug, not a supplement. It is included here for reference because people research and discuss it (often used off-label) — not as a recommendation. Take it only under a qualified clinician's supervision and only as prescribed; do not source it from grey-market vendors, where identity, purity, and dosing are unverified. The evidence below reflects its clinical trials.
What the evidence says
Most Ciclopirox studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 2000–2023 with a typical study size of 460 participants.
Based on 9 studies · 2 meta-analyses · 5 RCTs · 13,919 total participants
Confidence
High confidenceBy outcome
Scored on efficacy confidence, not on how well studied it is, and those point in opposite directions here. The evidence base is strong: a 2020 Cochrane review, a network meta-analysis, and phase III trials running to hundreds of patients each. What that evidence shows is a modest drug. Mycological cure is reliably better than vehicle (RR 3.15, 95% CI 1.93-5.12, moderate-quality). Complete cure, the endpoint a patient actually cares about, is rated LOW quality by Cochrane with a confidence interval running from 1.72 to 50.14, and the most recent phase III found no significant difference in complete cure against vehicle at all. Held at Moderate rather than higher because the endpoint that matters is the weakest one.
Ciclopirox 8% nail lacquer was the first topical antifungal the FDA approved for onychomycosis, the fungal infection that thickens, discolours and crumbles toenails. It is painted on daily for 48 weeks.
It belongs on a nail goal for one reason and it is worth stating plainly: a large share of nails that look weak, ridged or crumbling are infected rather than brittle, and no amount of biotin or collagen touches an infection. If that is what you have, this is the category of answer.
If your nails are genuinely brittle and splitting, with no fungal diagnosis, this is not your answer and a keratolytic humectant is a better place to start. The evidence base is unusually good for a topical and the results are unusually modest.
Mycological cure, meaning the laboratory can no longer find the fungus, runs around 34% against 10% on the vehicle in the pivotal US trials.
Complete cure, meaning that plus a nail that actually looks normal, is much rarer, and a 2023 phase III trial found no significant difference in complete cure between ciclopirox, its vehicle and an active comparator. Oral terbinafine outperforms every topical in network meta-analysis.
The practical problem is daily application for a year, which most people do not complete.
Ciclopirox is a hydroxypyridone, not an azole. It binds trivalent metal cations such as iron, which shuts down the metal-dependent enzymes a fungus needs for energy production and for degrading peroxides. Because the target is different from the azoles and allylamines, cross-resistance with terbinafine or itraconazole is not expected.
The nail plate is a poor route for any drug. The 8% lacquer forms a film that leaves ciclopirox against the nail as the solvent evaporates, with concentration building over repeated daily applications. Reformulation work has focused almost entirely on getting more drug through the plate, which is why water-soluble and hydroxypropyl-chitosan versions exist.
Consult a clinician before use. Systemic absorption through the nail plate is low, but no adequate trials in pregnancy exist and onychomycosis treatment is not urgent, so deferring it is the usual course.
A randomised vehicle-controlled trial in 40 children aged 2 to 16 with non-matrix onychomycosis reported 77% mycological cure at 32 weeks against 22% on vehicle, with weekly lacquer removal and trimming. Still a clinician's decision.
A 70-person randomised pilot found no reduction in foot ulceration over 12 months, so it is not a prophylactic against ulcers. It did leave significantly fewer people with clinically diagnosed hyperkeratosis or tinea pedis at study end, 52.9% against 77.8%.
The medicated lacquer has to sit against the nail plate to work. Nail polish over or under it is a delivery question rather than a drug interaction, and the trial regimen did not include cosmetic polish.
Ciclopirox has an evidence score of 5/10 — moderate evidence based on 9 indexed studies, including 2 meta-analyses. A topical antifungal nail lacquer for fungal nail infection. It clears the fungus in roughly a third of people and leaves a normal-looking nail in far fewer. Representative study: PMID 31978269.
The commonly studied dose of Ciclopirox is Ciclopirox 8% nail lacquer applied once daily over the entire nail plate and about 5 mm of surrounding skin, on all affected nails. Removed weekly with alcohol, with loose nail trimmed back. Continue for 48 weeks. A prescription medicine and a clinician's decision.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
The best time to take Ciclopirox is in the evening. It can be taken on an empty stomach. No time-of-day pharmacology.
Ciclopirox is generally safe at recommended doses, with a few precautions worth noting. The most commonly reported side effects are application-site reaction, redness or irritation of the surrounding skin, nail changes including altered colour or shape. Use caution if any of these apply to you: Known hypersensitivity to ciclopirox or any lacquer excipient.
Urea
Mostly mechanism / observationalA humectant at low strength and a keratolytic at high strength — one of the oldest, safest topicals, and rarely proven better than a cheap plain moisturiser.
Caffeine
Likely helpsBlocks adenosine receptors to boost alertness, reaction time, and endurance — one of the most proven ergogenic aids.
Adapalene
Mostly mechanism / observationalA modern topical retinoid for acne — now available over the counter (0.1%) as well as by prescription (0.3%). A drug, not a supplement or cosmetic. Adapalene is a third-generation retinoid selective for the retinoic-acid receptor beta; it normalizes how skin cells shed (comedolytic) and is anti-inflammatory. The honest framing: this is one of the best-evidenced acne treatments — a 5-trial meta-analysis and a 40-trial network meta-analysis show it matches tretinoin's efficacy with faster onset and notably better tolerability, and the adapalene-benzoyl peroxide combination is among the most effective regimens available. Caveats: it still causes retinoid irritation and slow onset, it is not superior to (only as good as) other retinoids, and — as a retinoid — it is generally avoided in pregnancy.
Benzoyl Peroxide
Mostly mechanism / observationalA frontline over-the-counter acne medicine applied to the skin — a drug, not a supplement or cosmetic. Benzoyl peroxide (BPO) kills the acne bacterium Cutibacterium (Propionibacterium) acnes by an oxidative mechanism that, crucially, does NOT drive antibiotic resistance, and it is also mildly comedolytic and anti-inflammatory. The honest framing: this is one of the best-evidenced topical acne treatments — a 120-trial Cochrane review and a 35-RCT network meta-analysis show it beats placebo and matches topical antibiotics — but it commonly causes dryness and irritation, it bleaches fabrics, towels, and hair, and BPO monotherapy is consistently outperformed by fixed combinations (adapalene-BPO, clindamycin-BPO). A genuinely effective acne drug with real, manageable downsides.
Explore: Best supplements for Skin, Hair & Beauty
Reviewed by Dr. Baher Al Hakim · Last reviewed September 2026 · evidence from 9 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.